Cite

    Sasaki, K. et al. (2015). Relative survival in patients with chronic-phase chronic myeloid leukaemia in the tyrosine-kinase inhibitor era: analysis of patient data from six prospective clinical trials. Lancet. 2 (5), pp. e186-e193. [Online].